Unlike the more common Zaire strain, there are no approved medical interventions for deadly Bundibugyo

DR Congo is exploring emergency treatment options, including an experimental US-developed antibody, as health officials race to contain the Ebola outbreak in the country’s east.

GENEVA: The World Health Organization said Thursday its advisory groups had recommended clinical trials for vaccines and treatments that could be useful against the Bundibugyo…

The WHO has identified promising treatments and vaccines for the rare Ebola strain killing hundreds in the Democratic Republic of Congo, but none are ready yet.

The virus causing an outbreak in Congo suspected of killing more than 200 people is less common than others that cause Ebola disease, which is complicating the response because…

WHO recommends two Ebola vaccine candidates for trials as Bundibugyo outbreak spreads in DRC and Uganda with no approved treatment yet.

Unlike the more common Zaire strain, there are no approved medical interventions for deadly Bundibugyo